IBRX vs ZBRA · rev $51.2M vs P/E 28, rev $3.05B
Immunitybio Inc (IBRX) versus Zebra Technologies Corporation (ZBRA) — a side-by-side from cached financials, not a winner call.
Immunitybio Inc (IBRX) is a biotechnology company listed on US.
Zebra Technologies Corporation (ZBRA) is a communication equipment company listed on NASDAQ.
Latest reported IBRX revenue for 2026-06-30 was $51.2M. Net income was -$230.4M. Revenue was up 15.9% from 2026-03-31 to 2026-06-30. IBRX currently screens at market cap $7.88B.
Latest reported ZBRA revenue for 2026-07-04 was $3.05B. Net income was $368.0M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
IBRX currently screens at market cap $7.88B. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
Not investment advice. Open the IBRX and ZBRA stock pages for the full models.
Not investment advice.